<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Advances in Medical and Biomedical Research</title>
<title_fa>Journal of Advances in Medical and Biomedical Research</title_fa>
<short_title>J Adv Med Biomed Res</short_title>
<subject>Medical Sciences</subject>
<web_url>http://journal.zums.ac.ir</web_url>
<journal_hbi_system_id>52</journal_hbi_system_id>
<journal_hbi_system_user>journal52</journal_hbi_system_user>
<journal_id_issn>1606-9366</journal_id_issn>
<journal_id_issn_online>2676-6264</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.30699/jambr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1400</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2021</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<volume>29</volume>
<number>137</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Comparative Evaluation of Mx and Alum as Bio and Conventional Adjuvants in Inducing Immune Responses by Influenza DNA Vaccine</title>
	<subject_fa>Medical Biology</subject_fa>
	<subject>Medical Biology</subject>
	<content_type_fa>مقاله پژوهشی</content_type_fa>
	<content_type>Original Research Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:16px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;color:#ffffff;&quot;&gt;&lt;strong&gt;&lt;span style=&quot;background-color:#16a085;&quot;&gt;Background &amp; Objective&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;background-color:#16a085;&quot;&gt;:&lt;/span&gt;&lt;/span&gt; DNA vaccines as a new generation of vaccines require adjuvant to improve vaccine immunogenicity; adjuvants can also increase the DNA vaccine efficacy. In this study, the effects of the host&amp;rsquo;s interferon-inducible Mx protein as bio adjuvant and conventional alum adjuvant were evaluated. &amp;nbsp;&lt;br&gt;
&lt;span style=&quot;color:#ffffff;&quot;&gt;&lt;strong&gt;&lt;span style=&quot;background-color:#16a085;&quot;&gt;Materials &amp; Methods&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;background-color:#16a085;&quot;&gt;:&lt;/span&gt;&lt;/span&gt; The BALB/c mice were immunized by different prime-boost strategies of the alum and Mx adjuvanted-HA2 DNA vaccine; they were challenged with the specific influenza virus. The potency and safety were evaluated. Humoral immune response was assayed by haemagglutination and virus neutralization tests. The induction of cell-mediated immune responses was determined using an MTT assay. The safety of vaccine regarding side effects occurrence was assessed by observation and histopathologic evaluation.&lt;br&gt;
&lt;span style=&quot;color:#ffffff;&quot;&gt;&lt;strong&gt;&lt;span style=&quot;background-color:#16a085;&quot;&gt;Results&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;background-color:#16a085;&quot;&gt;:&lt;/span&gt;&lt;/span&gt; Mx as a host defense peptide was able to increase the immune response against influenza better than alum adjuvant (p&lt;0.01). By HA2 and Mx in prime and boost strategy, the highest level of specific antibodies developed; they are capable of inducing cell-mediated immune responses. Results indicated that Mx in the DNA vaccine could induce stronger immune responses without any side effects; but alum had some local and general reactions.&lt;br&gt;
&lt;span style=&quot;color:#ffffff;&quot;&gt;&lt;strong&gt;&lt;span style=&quot;background-color:#16a085;&quot;&gt;Conclusion:&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt; The Mx could effectively enhance immune responses; it has the potential to enhance the vaccine immunogenicity.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Influenza vaccine, Humoral and cellular responses, HA2, Mx, bio adjuvant, Alum adjuvant</keyword>
	<start_page>331</start_page>
	<end_page>338</end_page>
	<web_url>http://journal.zums.ac.ir/browse.php?a_code=A-10-5675-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Sina</first_name>
	<middle_name></middle_name>
	<last_name>Soleimani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>s.soleimani@rvsri.ac.ir</email>
	<code>5200319475328460063971</code>
	<orcid>5200319475328460063971</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Razi Vaccine &amp; Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Shahla</first_name>
	<middle_name></middle_name>
	<last_name>Shahsavandi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>sh.shahsavandi@rvsri.ac.ir</email>
	<code>5200319475328460063972</code>
	<orcid>5200319475328460063972</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Razi Vaccine &amp; Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
